Unicar-Therapy

Unicar-Therapy is a Shanghai CAR-T developer founded in 2015 that builds its own cell therapy products on in-house platforms with integrated manufacturing. Its registered pipeline covers blood cancers and solid tumours. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT05768529 (phase 1/2, Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma) and NCT07036250 (phase 1/2, Clinical Study of U32 in Patients With Acute Myeloid Leukemia). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.